ARID1A and uterine carcinosarcoma: Intriguingly, 5 out of 57 primary tumors (8.8%) profiled in the TCGA uterine carcinosarcoma (UCS) data set harbored mutations in both TP53 and ARID1A in the absence of hypermutator signatures [20].